Share chart Poseida Therapeutics, Inc.
Extended chart
Simple chart
About Poseida Therapeutics, Inc.
Poseida Therapeutics, Inc., биофармацевтическая компания, работающая на клинической стадии, специализируется на разработке терапевтических средств для пациентов с высокими неудовлетворенными медицинскими потребностями. Компания разрабатывает линейку решений для лечения гематологических злокачественных новообразований и солидных опухолей, а также программы vivo для лечения редких заболеваний, направленных на печень. Кроме того, он предлагает терапию CAR-T для лечения рака. more details| IPO date | 2020-07-10 |
|---|---|
| ISIN | US73730P1084 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | http://www.poseida.com |
| Цена ао | 9.5 |
| Change price per day: | 0% (9.5) |
|---|---|
| Change price per week: | 0% (9.5) |
| Change price per month: | +0.1054% (9.49) |
| Change price per 3 month: | +294.19% (2.41) |
| Change price per half year: | +135.15% (4.04) |
| Change price per year: | +196.88% (3.2) |
| Change price per 3 year: | +166.85% (3.56) |
| Change price per 5 year: | 0% (9.5) |
| Change price per 10 year: | 0% (9.5) |
| Change price per year to date: | +0.1054% (9.49) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| FMR, LLC | 14343665 | 14.87 |
| Pentwater Capital Management LP | 5975000 | 6.19 |
| Blackrock Inc. | 5031173 | 5.21 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 3705779 | 3.84 |
| Vanguard Group Inc | 2899319 | 3 |
| Geode Capital Management, LLC | 1523055 | 1.58 |
| State Street Corporation | 1379519 | 1.43 |
| Aisling Capital Management LP | 1043267 | 1.08 |
| Blair (William) & Company, L.L.C. | 682742 | 0.71 |
| Millennium Management LLC | 592578 | 0.61 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| Global X Genomics & Biotechnology ETF | 0.44445 | 2.58 | 0.15585 |
| iShares Micro-Cap ETF | 0.05852 | 17.09 | 1.54048 |
| Goldman Sachs ActiveBeta US Small Cap Equity ETF | 0.02216 | 31.36 | 1.41955 |
| Vanguard Russell 2000 ETF | 0.01 | 17.16 | 1.48801 |
| Avantis U.S Small Cap Equity ETF | 0.00832 | 27.77 | 1.68271 |
Schwab U.S. Small-Cap ETF
|
0.00543 | 17.47 | 1.51433 |
ProShares UltraPro Russell2000
|
0.005 | 89.82 | 1.47873 |
iShares Russell 2000 Growth ETF
|
0.0048 | 38.04 | 0.6026 |
| ProShares Hedge Replication ETF | 0.00148 | 5.92 | 1.47892 |
| Avantis U.S. Equity ETF | 0.00043 | 23.04 | 1.59151 |
| Dimensional US Core Equity Market ETF | 0.00032 | 30.98 | 1.40618 |
Schwab U.S. Broad Market ETF
|
0.00028 | 24.86 | 1.43354 |
| Dimensional U.S. Equity ETF | 0.00015 | 31.53 | 1.3557 |
| Dimensional U.S. Core Equity 2 ETF | 0.00011 | 30.76 | 1.47098 |
| Vanguard Russell 2000 Growth ETF | 0 | 23.05 | 0.60264 |
| Vanguard Russell 3000 ETF | 0 | 31.87 | 1.43817 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Ms. Johanna M. Mylet CPA | Chief Financial Officer | N/A | 1988 (37 years) |
| Ms. Kristin Martin | Chief People & Administration Officer | N/A | |
| Mr. Mark J. Gergen J.D. | Executive Chairman of the Board | 920.74k | 1963 (62 years) |
| Dr. Devon J. Shedlock Ph.D. | Chief Scientific Officer of Cell Therapy | N/A | |
| Ms. Lisa Portale | Senior Vice President of Regulatory Affairs | N/A | |
| Mr. Harry J. Leonhardt Esq., J.D. | General Counsel, Chief Compliance Officer & Corporate Secretary | 630.23k | 1957 (68 years) |
| Mr. Loren Wagner | Chief Operations Officer | N/A | |
| Dr. Kristin Yarema Ph.D. | President, CEO & Director | N/A | 1971 (54 years) |
| Mr. Alexander Chapman | Senior VP of Investor Relations & Corporate Communications | N/A | |
| Dr. Jeffrey W. Winkelman J.D., Ph.D. | Senior VP & Chief Patent Counsel |
Address: United States, San Diego, CA , 9390 Towne Centre Drive - open in Google maps, open in Yandex maps
Website: http://www.poseida.com
Website: http://www.poseida.com
